Responsibility

Protecting human health takes action on nature as well as climate

Having a net positive impact on nature is fundamental to our purpose

Action on nature
0:40
Close Video

Our strategy

We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.

Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

Infectious diseases
1 in 3
of us will be affected by shingles in our lifetime
HIV
38m
people are living with HIV worldwide
Oncology
~10m
people died from cancer in 2020, making it a leading cause of death worldwide
Immunology
25yrs
of leading research to help people with inflammatory conditions
Life at GSK

How we help people thrive 

Studio portrait - light background - 8

Culture

Man smiling

Growth

Man smiling

Diversity, equity and inclusion

Scientists conversing over skeletal formulae

Wellbeing

icon

Positively impacting society and the planet

Baby laughing

Pricing and access

We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships.

Scientist inspecting a vial

Global health and health security

We are committed to using our science, our partnerships, and the knowledge we’ve gained from addressing the world’s biggest health challenges to improve health globally.

Scientist in laboratory

Diversity, equity and inclusion

Our work supports the health of all kinds of people. To meet our diverse patients' needs better, we need diversity in our clinical trials and to support our own people to thrive as part of an inclusive team.

Young girl leaving front door

Environmental sustainability

We are working towards a net zero impact on climate and a net positive impact on nature by 2030, across our full value chain.

Scientist in conversation

Product governance

Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together.

Group of scientists in the lab

Ethical standards

Our culture guides our people to do the right thing and act on any concerns they have.

INVESTORS

We announced our third quarter 2022 results on Wednesday 2 November.

View latest results
Back to top